Ama Fianu’s Story: A Journey of Hope and Equal Access to CML Care

Ama Fianu from Sunyani, Ghana, was diagnosed with Chronic Myeloid Leukemia (CML) in 2006. Like many people receiving a cancer diagnosis, Ama faced uncertainty, fear, and questions about her future. Her journey reflects the courage of thousands of people living with CML worldwide.
Before diagnosis, people living with CML may experience symptoms such as persistent tiredness, weakness, unexplained weight loss, frequent infections, night sweats, abdominal discomfort, easy bruising, or changes in their general wellbeing. Early recognition and timely diagnosis are critical in improving outcomes.
Over the years, advances in CML treatment, including targeted therapies such as tyrosine kinase inhibitors (TKIs), have transformed the lives of many patients. However, successful care requires more than medicine alone. Patients need regular monitoring, access to healthcare professionals, affordable treatment, reliable information, and emotional support.
Ama’s story reminds us that people living with CML are not defined by their diagnosis. With proper care, support, and hope, patients can continue to contribute to their families and communities.
However, many patients still face barriers, including limited awareness, delayed diagnosis, high healthcare costs, unequal access to specialist services, and challenges accessing continuous monitoring.
Ama’s message is simple:
“A CML diagnosis may bring fear, but it should not take away hope. Every patient deserves the opportunity to receive timely diagnosis, affordable treatment, and compassionate care. No one should be left behind because of where they live or their financial situation.”
On World CML Day 2026, Ama Fianu’s story stands as a reminder that every patient voice matters. Together, we must continue advocating for equitable access to CML care so that every person living with CML can live with dignity, hope, and opportunity.
#WCMLD26
#CMLAwareness
#HealthEquity
#PatientVoices